extracorporeal dialysis solution regeneration in 2005 and continued with extracorporeal heart failure treatment in 2013. Our goal is to develop medical devices for wearable ultrafiltration and dialysis. Patient safety is fundamental and our highest priority.

Every day we work with the implementation of carefully controlled product development processes within and around Triomed and its products.

We value our external partners and work in close cooperation with them. All medical staff and patients will be trained in the correct way of using our products.

For top production performance and distribution of Triomed’s specifications, we follow the laws and regulations applicable to the field of industry to ensure compliance with MDD 93/42/EEC and applicable ISO standards.